SXHHF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 SXHHF pulled ahead of the other in Year 1
Combined, SXHHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SXHHF + JNJ for your $10,000?
Sonomax Technologies Inc. engages in the development and licensing of intra-ear technology for hearing protection, hearing enhancement, and other auditory applications. The company offers custom-fitted hearing protection and communication enhancement products; and functional accessories, such as Sonomax Self-Fit hearing protection faceplate to support third party acoustic tube radio solutions and Sonomax Quick-Fit lubricant. It also provides SonoPass proof of performance software for validating earpiece performance; and earpiece solutions that are plug and play with multiple radio systems. Sonomax Technologies Inc. sells its products through industrial wholesalers, CE retail distributors, and OEMs primarily in Australia, Canada, Europe, and the United States. The company was formerly known as Sonomax Hearing Healthcare Inc. and changed its name to Sonomax Technologies Inc. in March 2010. The company was founded in 1998 and is headquartered in Montreal, Canada.
Full SXHHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.